Abstract
A planar, polycyclic and aromatic hydrocarbon ligand, namely 9,10-phenanthrenequinone semicarbazone, and its transition metal complexes have been synthesized and structurally characterized. The in vitro antiproliferative activity of these compounds against five human cancer cell lines revealed that they were effective against androgen receptor-positive/negative prostate cancer cells as well as COX-positive pancreatic BxPC-3 cancer cell line. The driving force behind such antiproliferative activity seems to be the up-regulated COX expression in these cells, which was amenable for targeting through metal complexation. These structural motifs can, therefore, serve as a starting point for developing novel cytotoxic agents against the growing number of prostate and pancreatic cancers.
Similar content being viewed by others
References
Siegel R, Ward E, Brawley O, Jemal A (2011) CA Cancer J Clin 62:10–29
Pienta K, Bradley D (2006) Clin Cancer Res 12:1665–1671
Stanway S, Purohit A, Woo L, Sufi S, Vigushin D, Ward R, Wilson R, Stanczyk F, Dobbs N, Kulinskaya E (2006) Clin Cancer Res 12:1585–1592
Mizokami A, Koh E, Fujita H, Maeda Y, Egawa M, Koshida K, Honma S, Keller E, Namiki M (2004) Cancer Res 64:765–771
Bracarda S, de Cobelli O, Greco C, Prayer-Galetti T, Valdagni R, Gatta G, de Braud F, Bartsch G (2005) Crit Rev Oncol Hematol 56:379–396
Donovan MJ, Osman I, Khan FM, Vengrenyuk Y, Capodieci P, Koscuiszka M, Anand A, Cordon-Cardo C, Costa J, Scher HI (2010) BJU Int 105:462–467
O’Neill GP, Ford-Hutchinson AW (1993) FEBS Lett 330:156–160
Gupta S, Srivastava M, Ahmad N, Bostwick DG, Mukhtar H (2000) Prostate 42:73–78
Yoshimura R, Sano H, Masuda C, Kawamura M, Tsubouchi Y, Chargui J, Yoshimura N, Hla T, Wada S (2000) Cancer 89:589–596
Madaan S, Abel PD, Chaudhary KS, Hewitt R, Stott MA, Stamp GW, Lalani EN (2000) BJU Int 86:736–741
Hermanova M, Trna J, Nenutil R, Dite P, Kala Z (2008) Eur J Gastroenterol Hepatol 20:732–739
Xu L, Li YM, Yu CH, Li L, Liu YS, Zhang BF, Fang J, Zhou Q, Hu Y, Gao HJ (2006) Hepatobiliary Pancreat Dis Int 5:138–142
Ahmed F, Adsule S, Ali AS, Banerjee S, Ali S, Kulkarni S, Padhye S, Sarkar FH (2007) Int J Cancer 120:734–742
Sarkar FH, Adsule S, Li Y, Padhye S (2007) Mini Rev Med Chem 7:599–608
Kovács A, Vasas A, Hohmann J (2008) Phytochemistry 69:1084–1110
Ju JH, Yang JS, Li J, Xiao PG (2000) Chin Chem Lett 11:37–38
Chen Y, Liu Y, Jiang J, Zhang Y, Yin B (2008) Food Chem 11:111–112
Lee CL, Chang FR, Yen MH, Yu D, Liu YN, Bastow KF, Morris-Natschke SL, Wu YC, Lee KH (2009) J Nat Prod 72:210–213
Kuo CT, Hsu MJ, Chen BC, Chen CC, Teng CM, Pan SL, Lin CH (2008) Toxicol Lett 177:48–58
Yang KC, Uen YH, Suk FM, Liang YC, Wang YJ, Ho YS, Li IH, Lin SY (2005) World J Gastroenterol 11:3040–3045
Chen TH, Pan SL, Guh JH, Chen CC, Huang YT, Pai HC, Teng CM (2008) Naunyn Schmiedebergs Arch Pharmacol 378:447–457
Sánchez-Duffhues G, Calzado MA, de Vinuesa AG, Appendino G, Fiebich BL, Loock U, Lefarth-Risse A, Krohn K, Muñoz E (2009) Biochem Pharmacol 77:1401–1409
Flowers-Geary L, Bleczinki W, Harvey RG, Penning TM (1996) Chem Biol Interact 99:55–72
Matsunaga T, Arakaki M, Kamiya T, Haga M, Endo S, El-Kabbani O, Hara A (2010) Toxicology 268:191–197
Powell AK (1951) Br J Cancer 5:264–272
Murugkar A, Unnikrishnan B, Padhye S, Bhonde R, Teat S, Triantafillou E, Sinn E (1999) Met Based Drugs 6:177–182
West DX, Liberta AE, Padhye SB, Chikate RC, Sonawane PB, Kumbhar AS, Yerande RG (1993) Coord Chem Rev 123:49–71
Padhyé SB, Kauffman GB (1985) Coord Chem Rev 63:127–160
Kalinowski DS, Quach P, Richardson DR (2009) Future Med Chem 1:1143–1151
Lobana TS, Sharma R, Bawa Ga, Khanna S (2009) Coord Chem Rev 253:977–1055
Dutta S, Padhye S, Priyadarsini KI, Newton C (2005) Bioorg Med Chem Lett 15:2738–2744
Padhye S, Afrasiabi Z, Sinn E, Fok J, Mehta K, Rath N (2005) Inorg Chem 44:1154–1156
Peters ZJ, Nykamp JA, Passaperuma K, Carlson JC, DeWitte-Orr SJ, Greenberg BM, Bols NC (2007) Reprod Toxicol 23:513–520
Ahmad A, Wang Z, Kong D, Ali R, Ali S, Banerjee S, Sarkar FH (2011) Breast Cancer Res Treat 126:15–25
Bruker (2002) SMART. Bruker AXS Inc., Madison
Bruker (2008) SAINT and SADABS. Bruker AXS Inc., Madison
Sheldrick GM (2008) Acta Cryst A64:112–122
Spek AL (2005) PLATON, a multipurpose crystallographic tool. Utrecht University, Utrecht
Akinchan NT, Akinchan R, West DX, Yang YH (1994) Transition Met Chem 19:135–140
Chandra S, Gupta LK (2005) Spectrochim Acta A 61:269–275
Mishra N, Mohapatra B, Guru S (1979) J Inorg Nucl Chem 41:408–410
Rodríguez-Argüelles MC, Mosquera-Vázquez S, Sanmartín-Matalobos J, García-Deibe AM, Pelizzi C, Zani F (2010) Polyhedron 29:864–870
Saleh AA, Khalil SME, Eid MF, El-Ghamry MA (2003) J Coord Chem 46:467–480
West DX, Carlson CS, Galloway CP, Liberta AE, Daniels CR (1990) Transition Met Chem 15:91–95
Seleem HS, El-Shetary BA, Khalil SME, Mostafa M, Shebl M (2005) J Coord Chem 58:479–493
Ismail TMA, Saleh AA (2000) Egypt J Chem 43:227–235
Labisbal E, Sousa A, Castineiras A, Garacıa-Vazquez JA, Romero J, West DX (2000) Polyhedron 19:1255–1262
Satpathy KC, Mishra R, Jal BB (1986) J Indian Chem Soc 68:377–379
König E (1971) Struct Bond (Berlin) 9:175–212
Afrasiabi Z, Sinn E, Lin W, Ma Y, Campana C, Padhye S (2005) J Inorg Biochem 99:1526–1531
Dutta S, Peng SM, Bhattacharya S (2000) Inorg Chem 39:2231–2234
Goodman JH, Reibenspies N, Goswami S, Jurisson MY (1997) J Am Chem Soc 119:4955–4963
Blake AJ, Gould RO, Halcrow MA, Schröeder M (1993) J Chem Soc Dalton Trans 19:2909–2920
Matsuzaki SY, Gotoh M, Kuboyama A (1987) Mol Cryst Liq Cryst 142:127–139
Jouad EM, Allian M, Khan MA, Bouet GM (2005) Polyhedron 24:327–332
Pal I, Dutta S, Basuli F, Goverdhan S, Peng S, Lee G, Bhattacharya S (2003) Inorg Chem 42:4338–4345
Basuli F, Peng S, Bhattacharya S (2001) Inorg Chem 40:1126–1133
Padhye S, Dandawate P, Yusufi M, Ahmad A, Sarkar FH (2012) Med Res Rev 32:1131–1158
Chen J, Huang YW, Liu G, Afrasiabi Z, Sinn E, Padhye S, Ma Y (2004) Toxicol Appl Pharmacol 197:40–48
Chikate RC, Padhye SB (2007) Spectrochim Acta A Mol Biomol Spectrosc 66:1091–1096
Gokhale NH, Shirisha K, Padhye SB, Croft SL, Kendrick HD, Mckee V (2006) Bioorg Med Chem Lett 16:430–432
Gokhale NH, Padhye SB, Croft SL, Kendrick HD, Davies W, Anson CE, Powell AK (2003) J Inorg Biochem 95:249–258
Liguori PF, Valentini A, Palma M, Bellusci A, Bernardini S, Ghedini M, Panno ML, Pettinari C, Marchetti F, Crispini A, Pucci D (2010) Dalton Trans 39:4205–4212
Ambike V, Adsule S, Ahmed F, Wang Z, Afrasiabi Z, Sinn E, Sarkar F, Padhye S (2007) J Inorg Biochem 101:1517–1524
Acknowledgments
S.P. and A.V. are thankful to Mr. P. A. Inamdar and Dr. E. M. Khan for their keen interest and encouragement.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Afrasiabi, Z., Almudhafar, R., Xiao, D. et al. Metal-based anticancer agents: targeting androgen-dependent and androgen-independent prostate and COX-positive pancreatic cancer cells by phenanthrenequinone semicarbazone and its metal complexes. Transition Met Chem 38, 665–673 (2013). https://doi.org/10.1007/s11243-013-9735-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11243-013-9735-3